Article 1 to 2 out of 2 concerning Jerini Ophthalmic, Inc.
Shire to add new orphan drug to its HGT portfolio(07/07/2008) Jerini AG for an equity purchase price of EUR328 million Shire Limited, the global specialty biopharmaceutical company, announced that Maia Elfte Vermögensverwaltungs-GmbH, to be renamed "Shire Deutschland Investments GmbH", a German indirect subsidiary of Shire Limited, will launch a voluntary public ...
Top